Intranasal administration: a potential solution for cross-BBB delivering neurotrophic factors

J Zhu, Y Jiang, G Xu, X Liu - 2012 - digitum.um.es
Neurotrophic factors (NTFs) are endogenous polypeptides that regulate the growth, survival,
differentiation, and functioning of neurons. The neuroprotective effects of NTFs in …

[HTML][HTML] Getting into the brain: The intranasal approach to enhance the delivery of nerve growth factor and its painless derivative in Alzheimer's disease and down …

S Capsoni, A Cattaneo - Frontiers in Neuroscience, 2022 - frontiersin.org
The neurotrophin Nerve Growth Factor (NGF) holds a great potential as a therapeutic
candidate for the treatment of neurological diseases. However, its safe and effective delivery …

Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations

RG Thorne, WH Frey - Clinical pharmacokinetics, 2001 - Springer
Neurotrophic factors are proteins with considerable potential in the treatment of central
nervous system (CNS) diseases and traumatic injuries. However, a significant challenge to …

Intranasal delivery of therapeutic proteins for neurological diseases

F Malerba, F Paoletti, S Capsoni… - Expert opinion on drug …, 2011 - Taylor & Francis
Introduction: Among the range of therapeutic protein candidates for new generation
treatments of neurological diseases, neurotrophic factors and recombinant antibodies hold …

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS

SR Alcalá-Barraza, MS Lee, LR Hanson… - Journal of drug …, 2010 - Taylor & Francis
Injury to the central nervous system (CNS) generally results in significant neuronal death
and functional loss. In vitro experiments have demonstrated that neurotrophic factors such …

[HTML][HTML] Intranasal delivery of nerve growth factor in neurodegenerative diseases and neurotrauma

L Manni, G Conti, A Chiaretti, M Soligo - Frontiers in pharmacology, 2021 - frontiersin.org
Since the 1980s, the development of a pharmacology based on nerve growth factor (NGF)
has been postulated for the therapy of Alzheimer's disease (AD). This hypothesis was based …

Nanoformulation of brain‐derived neurotrophic factor with target receptor‐triggered‐release in the central nervous system

Y Jiang, JM Fay, CD Poon, N Vinod… - Advanced functional …, 2018 - Wiley Online Library
Brain‐derived neurotrophic factor (BDNF) is identified as a potent neuroprotective and
neuroregenerative agent for many neurological diseases. Regrettably, its delivery to the …

[HTML][HTML] Intranasal treatment of central nervous system dysfunction in humans

CD Chapman, WH Frey, S Craft, L Danielyan… - Pharmaceutical …, 2013 - Springer
One of the most challenging problems facing modern medicine is how to deliver a given
drug to a specific target at the exclusion of other regions. For example, a variety of …

Intranasal delivery: circumventing the iron curtain to treat neurological disorders

Y Jiang, Y Li, X Liu - Expert opinion on drug delivery, 2015 - Taylor & Francis
Introduction: The blood–brain barrier (BBB) is like an iron curtain that prevents exogenous
substances, including most drugs, from entering the CNS. Intranasal delivery has been …

[HTML][HTML] The nose may help the brain: intranasal drug delivery for treating neurological diseases

W Ying - 2008 - Future Medicine
While enormous progress has been made regarding our understanding of the pathogenic
mechanisms of neurological diseases, there are only a small number of effective drugs for …